Literature DB >> 25678876

Should "historic control" epilepsy monotherapy trials be "history"?

Gregory L Krauss.   

Abstract

Entities:  

Year:  2015        PMID： 25678876      PMCID： PMC4320965          DOI： 10.5698/1535-7597-15.1.8

Source DB:  PubMed          Journal:  Epilepsy Curr        ISSN： 1535-7511            Impact factor:   7.500


× No keyword cloud information.
  5 in total

Review 1.  Monotherapy trials: presurgical studies.

Authors:  G Pledger
Journal:  Epilepsy Res       Date:  2001-05       Impact factor: 3.045

2.  Pregabalin monotherapy in patients with partial-onset seizures: a historical-controlled trial.

Authors:  Jacqueline French; Patrick Kwan; Toufic Fakhoury; Verne Pitman; Sarah DuBrava; Lloyd Knapp; Lorraine Yurkewicz
Journal:  Neurology       Date:  2014-01-10       Impact factor: 9.910

3.  Oxcarbazepine (Trileptal) as monotherapy in patients with partial seizures.

Authors:  R Sachdeo; A Beydoun; S Schachter; B Vazquez; N Schaul; P Mesenbrink; L Kramer; J D'Souza
Journal:  Neurology       Date:  2001-09-11       Impact factor: 9.910

4.  Efficacy and tolerability of zonisamide versus controlled-release carbamazepine for newly diagnosed partial epilepsy: a phase 3, randomised, double-blind, non-inferiority trial.

Authors:  Michel Baulac; Martin J Brodie; Anna Patten; Joanna Segieth; Luigi Giorgi
Journal:  Lancet Neurol       Date:  2012-06-08       Impact factor: 44.182

5.  Adjunctive use of controlled-release pregabalin in adults with treatment-resistant partial seizures: a double-blind, randomized, placebo-controlled trial.

Authors:  Jacqueline French; Christian Brandt; Daniel Friedman; Victor Biton; Lloyd Knapp; Verne Pitman; Marci Chew; Sarah Dubrava; Holly B Posner
Journal:  Epilepsia       Date:  2014-06-24       Impact factor: 5.864
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.